Strategic Partnership to Accelerate Growth in Saudi Arabia and Across the MENA Region

Amman, Jordan/Riyadh, Saudi Arabia: MS Pharma today announced that Olayan Financing Company (OFC) has made a minority equity investment in the company. This partnership brings strategic depth to MS Pharma’s next phase of growth, underscoring its commitment to innovation, regional expansion, and long-term value creation. It also marks the beginning of a long-term partnership between OFC and MS Pharma’s existing majority shareholders, who have distinguished themselves through decades of leadership and excellence in the pharmaceutical sector.

As part of its ongoing efforts to strengthen collaboration with the pharmaceutical industry, the Vocational Training Corporation (VTC) signed a memorandum of understanding (MOU) with MS Pharma to advance training and employment initiatives, foster the development of specialized national talent within Jordan’s pharmaceutical sector, and enhance the alignment of vocational training outcomes with evolving labor market demands.

Riyadh, Saudi Arabia: MS Pharma Saudi Arabia, part of MS Pharma group, one of the leading pharmaceutical companies in the region has signed a memorandum of understanding  with Prince Sattam bin Abdulaziz University to advance talent management and strengthen the link between academia and the pharmaceutical industry in the Kingdom. The initiative supports national efforts to build a highly skilled workforce and contribute to the long-term growth of Saudi Arabia’s pharmaceutical sector, in line with Vision 2030. 

Riyadh, Saudi Arabia: MS Pharma Saudi Arabia, part of MS Pharma Group - One of the leading biopharmaceutical companies in the MENA region - sponsored the King Saud University Crossroads Career Event, held on 28 and 29 March, reaffirming its commitment to supporting and developing Saudi talent at the early stages of their professional journeys. Through its Talent Management team, alongside representatives from key business functions, MS Pharma engaged directly with high-potential fresh graduates, primarily from pharmacy and life sciences disciplines, as well as early-career professionals exploring opportunities within the pharmaceutical sector. 

Algiers, Algeria / Amman, Jordan —MS Pharma Group, a leading regional pharmaceutical company in the MENA region, has signed a strategic partnership agreement with Hetero Group, a global pharmaceutical company, to localize five established biosimilars across key therapeutic areas, including oncology, immunology and hematology.